| Literature DB >> 24497946 |
Shulei Qiu1, Jin Chen2, Tao Qin1, Yuanliang Hu1, Deyun Wang1, Qiang Fan3, Cunshuai Zhang3, Xingying Chen1, Xiaolan Chen1, Cui Liu1, Zhenzhen Gao1, Xiuping Li1.
Abstract
The garlic polysaccharide was modified by HNO3-Na2SeO3 method according to orthogonal design L9(3(4)) to obtain nine selenizing garlic polysaccharides, sGPS1-sGPS9. Their effects on chicken peripheral lymphocytes proliferation in vitro were compared by MTT assay. The results showed that sGPSs could significantly promote lymphocytes proliferation, sGPS3, sGPS5 and sGPS6 presented stronger efficacy. In vivo experiment, 14-day-old chickens were injected respectively with sGPS3, sGPS5 and sGPS6 when they were vaccinated with ND vaccine taking unmodified GPS as control. The results showed that three sGPSs could significantly promote lymphocyte proliferation, enhance serum antibody titer, IFN-γ and IL-2 contents. These results indicated that selenylation modification could significantly enhance the immune-enhancing activity of GPS, sGPS6 possessed the best efficacy and could be as a candidate drug of immunoenhancer. Its optimal modification conditions were 400 mg of sodium selenite for 500 mg of GPS, reaction temperature of 70°C and reaction time of 6 h.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24497946 PMCID: PMC3907442 DOI: 10.1371/journal.pone.0086377
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Modification conditions, yields and contents of selenium and carbohydrate of every sGPS.
| sGPS | A Temperature (°C) | B Na2SeO3(mg) | C Time(h) | Rate of Yeild (%) | Se content (mg·g−1) | Carbohydrate content (%) |
| sGPS1 | 50 | 200 | 6 | 36.90 | 6.94 | 46.4 |
| sGPS2 | 50 | 300 | 8 | 37.64 | 8.37 | 45.7 |
| sGPS3 | 50 | 400 | 10 | 27.65 | 12.49 | 45.2 |
| sGPS4 | 70 | 200 | 8 | 32.10 | 9.43 | 49.3 |
| sGPS5 | 70 | 300 | 10 | 30.25 | 10.45 | 56.9 |
| sGPS6 | 70 | 400 | 6 | 34.43 | 11.36 | 52.6 |
| sGPS7 | 90 | 200 | 10 | 18.10 | 6.21 | 21.2 |
| sGPS8 | 90 | 300 | 6 | 24.32 | 7.99 | 34.4 |
| sGPS9 | 90 | 400 | 8 | 19.30 | 8.76 | 24.7 |
The cellular A 570 values of every group in vitro test.
| Concentration (µg•mL−1) | sGPS1 | sGPS2 | sGPS3 | sGPS4 | sGPS5 |
| 3.125 | 0.268±0.003a | 0.199±0.004d | 0.242±0.005d | 0.270±0.006b | 0.276±0.004c |
| 1.563 | 0.244±0.004b | 0.213±0.004c | 0.282±0.006c | 0.291±0.004a | 0.301±0.005b |
| 0.781 | 0.232±0.004c | 0.242±0.004b | 0.312±0.006b | 0.277±0.005ab | 0.326±0.004a |
| 0.391 | 0.210±0.003d | 0.270±0.005a | 0.336±0.005a | 0.272±0.007b | 0.305±0.003b |
| 0.195 | 0.195±0.005e | 0.265±0.005a | 0.295±0.004c | 0.250±0.004c | 0.275±0.005c |
| CC | 0.192±0.001e | 0.177±0.001e | 0.204±0.004e | 0.210±0.005d | 0.200±0.003d |
Column data without the same superscripts (a–f) differ significantly (P<0.05). Values are mean ± standard error of the mean (SEM), n = 4/group.
Figure 1The lymphocyte proliferation rates of every group in vitro test.
Bars without the same superscripts (a–f) differ significantly (P<0.05).
Figure 2The cellular A 570 values of every group in vivo test.
Bars in same time point without the same superscripts (a–e) differ significantly (P<0.05).
Figure 3The average lymphocyte proliferation rates of every group in vivo test.
Bars without the same superscripts (a–c) differ significantly (P<0.05).
Figure 4The antibody titers of every group in vivo test.
Bars in same time point without the same superscripts (a–e) differ significantly (P<0.05).
Figure 5The serum IFN-γ contents of every group in vivo test.
Bars in same time point without the same superscripts (a–e) differ significantly (P<0.05).
Figure 6The serum IL-2 contents of every group in vivo test.
Bars in same time point without the same superscripts (a–f) differ significantly (P<0.05).